Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice Source: Eur Respir J, 50 (2) 1700148; 10.1183/13993003.00148-2017 Year: 2017
Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice Source: Eur Respir J, 50 (5) 1701984; 10.1183/13993003.01984-2017 Year: 2017
Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice Source: Eur Respir J, 50 (5) 1702135; 10.1183/13993003.02135-2017 Year: 2017
Possible neuropsychic adverse reactions with montelukast in childhood asthma Source: Eur Respir J 2001; 18: Suppl. 33, 263s Year: 2001
Montelukast: neuropsychiatric adverse drug reactions in Tunisian asthmatic children Source: International Congress 2018 – Paediatric asthma: new insights in its prevalence, treatment and treatment failure Year: 2018
Safety of montelukast in children with post-RSV-bronchiolitic respiratory symptoms Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007
Personality influences the reporting of side effects of inhaled corticosteroids Source: Annual Congress 2008 - Social determinants and psychological issues in primary care respiratory diseases Year: 2008
Adherence to inhaled controller therapy and local adverse events in children with asthma Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
Effect of fluticasone and montelukast in preschool children with asthma-like symptoms Source: Eur Respir J 2006; 28: Suppl. 50, 709s Year: 2006
The effect of inhaled corticosteroids on symptoms in pre-school children with asthma-like symptoms in general practice: the ASTERISK study Source: Eur Respir J 2004; 24: Suppl. 48, 165s Year: 2004
Low incidence of oropharyngeal adverse events in asthma patients treated with ciclesonide Source: Eur Respir J 2005; 26: Suppl. 49, 255s Year: 2005
Efficacy and systemic effects of ciclesonide and fluticasone in asthma patients Source: Eur Respir J 2001; 18: Suppl. 33, 147s Year: 2001
Neuropsychiatric side effects of tuberculosis Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012
Clinical disposition, safety and efficacy of fluticasone propionate (FP) in pre-school children with persistent wheeze and asthma-like symptoms Source: Eur Respir J 2002; 20: Suppl. 38, 219s Year: 2002
Efficacy of diltiazem administration on the respiratory adverse effects of enalapril Source: Eur Respir J 2002; 20: Suppl. 38, 303s Year: 2002
Monitoring asthma in children: treatment-related issues Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force Year: 2014
Neuropsychiatric toxicity during antituberculosis treatment Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007
Assessment of long-term effects of combined extra-fine beclomethasone and formoterol treatment in asthma patients using functional imaging Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010
Efficacy and safety of inhaled corticosteroids in combination with a long-acting beta2-agonist in asthmatic children under age 5 Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016
Impact of omalizumab in patients with severe asthma Source: Annual Congress 2009 - Aspects of uncontrolled asthma Year: 2009